Cipla to distribute Lilly’s diabetes drugs Humalog and Trulicity in India

By NS Healthcare Staff Writer

05 Oct 21

Cipla will expand access to Lilly’s diabetes drugs by leveraging its distribution capabilities and engaging its professionals

PharmaceuticalsPartnerships and Licensing Agreements

Merck, GSK terminate $4.5bn deal on cancer drug development

By NS Healthcare Staff Writer

01 Oct 21

The decision was based on discouraging clinical trial data to date, including results from the recent INTR@PID study…

PharmaceuticalsPartnerships and Licensing Agreements

Regeneron to supply additional doses of REGEN-COV to US government

By NS Healthcare Staff Writer

15 Sep 21

The biotechnology company will supply additional 1.4 million 1,200mg doses of REGEN-COV to the US government, at a…

PharmaceuticalsPartnerships and Licensing Agreements

AstraZeneca reaches settlement with EC over Vaxzevria delivery

By NS Healthcare Staff Writer

06 Sep 21

AstraZeneca will deliver 60 million doses by the end of Q3 2021, 75 million doses by the end…

PharmaceuticalsManufacturing

Roche, Shape collaborate on AAV-based gene therapies for neurological diseases

By NS Healthcare Staff Writer

25 Aug 21

Shape Therapeutics will use its RNA editing platform RNAfix and AAVid platform for the development of gene therapies…

PharmaceuticalsPartnerships and Licensing Agreements

Autolus, Moderna sign licencing agreement for mRNA therapeutics

By NS Healthcare Staff Writer

03 Aug 21

Moderna will make an upfront payment for each target it licensed from Autolus, in addition to milestone payments…

PharmaceuticalsBiotechnology Equipment and Materials

Biovac teams up with Pfizer and BioNTech to produce Covid-19 vaccine in Africa

By NS Healthcare Staff Writer

22 Jul 21

Pfizer and BioNTech will immediately start technical transfer, on-site development and equipment installation activities

PharmaceuticalsPartnerships and Licensing Agreements

Merck, Universal partner to produce paediatric treatment for schistosomiasis

By NS Healthcare Staff Writer

16 Jul 21

The new drug is currently being tested in a Phase 3 clinical trial in Kenya and Côte d’Ivoire

PharmaceuticalsManufacturing

Kintor, Fosun partner to commercialise proxalutamide in India and Africa

By NS Healthcare Staff Writer

15 Jul 21

The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…

PharmaceuticalsPartnerships and Licensing Agreements

BMS partners with Eisai to co-develop cancer drug candidate

By NS Healthcare Staff Writer

18 Jun 21

Under the deal, BMS will develop and commercialise the drug in regions outside of the collaboration territories, while…

PharmaceuticalsPartnerships and Licensing Agreements